Mice Without CB1 Receptors Are Protected from Inflammation-Induced Preterm Birth

Knocking out the CB1 cannabinoid receptor significantly reduced preterm birth rates in mice exposed to inflammation, identifying CB1 as a potential target for preterm birth prevention.

Marvaldi, Carolina et al.·Reproduction (Cambridge·2026·Preliminary Evidencepreclinical
RTHC-08466PreclinicalPreliminary Evidence2026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
preclinical
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

CB1-knockout mice showed significantly lower preterm birth rates compared to wild-type when exposed to LPS-induced inflammation. CB1 deficiency modulated endogenous lipids, reduced inflammatory markers (PGE2, PGF2α, MMP9), and altered fatty acid profiles in decidual tissue. Free fatty acids increased in wild-type decidua with inflammation but were unchanged in CB1-KO.

Key Numbers

CB1-KO: significantly lower PTB rates vs. wild-type. CB1-KO had lower basal FAAH activity. LPS elevated PGE2, PGF2α, and MMP9 in wild-type but not CB1-KO. Free fatty acids increased with LPS in wild-type only.

How They Did This

CB1-knockout and wild-type pregnant mice were treated with lipopolysaccharide to induce preterm birth. Decidual tissue analyzed for endocannabinoid system components, lipid profiles, and inflammatory markers including prostaglandins and matrix metalloproteinases.

Why This Research Matters

Preterm birth affects about 10% of pregnancies worldwide and is a leading cause of neonatal death. Identifying CB1 as a mediator of inflammation-induced preterm birth opens a new therapeutic target — though cannabis use during pregnancy remains contraindicated.

The Bigger Picture

This finding is a double-edged sword for cannabis science: while it identifies CB1 as a preterm birth target, it also implies that activating CB1 (which cannabis does) could promote preterm labor — reinforcing concerns about cannabis use during pregnancy.

What This Study Doesn't Tell Us

Mouse model with LPS-induced inflammation is one of many preterm birth mechanisms. Complete CB1 knockout may not reflect pharmacological CB1 modulation. Decidual tissue analysis may not capture all relevant reproductive tissues. Human translation uncertain.

Questions This Raises

  • ?Would CB1 antagonists prevent preterm birth in humans?
  • ?Does cannabis use during pregnancy increase preterm birth risk through this mechanism?
  • ?Could selective peripheral CB1 blockers be safe during pregnancy?

Trust & Context

Key Stat:
Evidence Grade:
Well-designed preclinical study with mechanistic evidence, but mouse preterm birth models have limited direct human clinical translation.
Study Age:
Published 2026, identifying a new endocannabinoid system role in pregnancy.
Original Title:
Cannabinoid receptor type 1 deficiency protects from lipopolysaccharide-induced preterm birth: the role of the decidual endocannabinoid system.
Published In:
Reproduction (Cambridge, England), 171(2) (2026)
Database ID:
RTHC-08466

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Is the endocannabinoid system involved in preterm birth?

Yes — this study found that removing the CB1 cannabinoid receptor significantly protected mice from inflammation-induced preterm birth, identifying the endocannabinoid system as a mediator of preterm labor.

Does this mean cannabis causes preterm birth?

The study suggests that CB1 receptor activation (which cannabis does) promotes inflammatory pathways that can lead to preterm labor. While this doesn't prove cannabis causes preterm birth, it provides a mechanistic reason to be cautious about cannabis use during pregnancy.

Read More on RethinkTHC

Cite This Study

RTHC-08466·https://rethinkthc.com/research/RTHC-08466

APA

Marvaldi, Carolina; Mirón Granese, Ayelén A; Johnson, Clare; Schander, Julieta A; Aisemberg, Julieta; Cella, Maximiliano; Correa, Fernando; Franchi, Ana M; Bradshaw, Heather B; Wolfson, Manuel L. (2026). Cannabinoid receptor type 1 deficiency protects from lipopolysaccharide-induced preterm birth: the role of the decidual endocannabinoid system.. Reproduction (Cambridge, England), 171(2). https://doi.org/10.1093/reprod/xaaf022

MLA

Marvaldi, Carolina, et al. "Cannabinoid receptor type 1 deficiency protects from lipopolysaccharide-induced preterm birth: the role of the decidual endocannabinoid system.." Reproduction (Cambridge, 2026. https://doi.org/10.1093/reprod/xaaf022

RethinkTHC

RethinkTHC Research Database. "Cannabinoid receptor type 1 deficiency protects from lipopol..." RTHC-08466. Retrieved from https://rethinkthc.com/research/marvaldi-2026-cannabinoid-receptor-type-1

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.